Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997

Radiation Research

Volumn 160, Issue 4, 2003, Pages 381-407

  Preston, Dale L ^a   Shimizu, Yukiko ^a   Pierce, Donald A ^a   Suyama, Akihiko ^a   Mabuchi, Kiyohiko ^a,b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER MORTALITY; CANCER RISK; DIGESTIVE SYSTEM DISEASE; FOLLOW UP; HEART DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RESPIRATORY TRACT DISEASE; STROKE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LEUKEMIA; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; PROPORTIONAL HAZARDS MODELS; RADIOMETRY; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVORS; TOPOGRAPHY, MEDICAL;

EID: 0141764894     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3049     Document Type: Article

References (87)

1. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat. Res. 146, 1-27 (1996).
2. Y. Shimizu, D. A. Pierce, D. L. Preston and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiat. Res. 152, 374-389 (1999).
3. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda and M. Terasaki, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
4. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy and T. Matsuo, Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (Suppl.), S68-S97 (1994).
5. D. A. Pierce and D. L. Preston, Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res. 154, 178-186 (2000).
6. T. Straume, S. D. Egbert, W. A. Woolson, R. C. Finkel, P. W. Kubik, H. E. Gove, P. Sharma and M. Hoshi, Neutron discrepancies in the DS86 Hiroshima dosimetry system. Health Phys. 63, 421-426 (1992).
7. 60Co activities induced by neutrons from the Hiroshima atomic bomb. Health Phys. 65, 272-282 (1993).
8. W. K. Sinclair, Status of the Dosimetry of the Radiation Effects Research Foundation (DS86). National Academy Press, Washington, DC, 2001.
9. G. Beebe and M. Usagawa, The Major ABCC Samples. TR 12-68, Atomic Bomb Casualty Commission, Hiroshima, 1968.
10. T. J. Francis, S. Jablon and F. Moore, Report of an Ad Hoc Committee for Appraisal of the ABCC Program 1955. TR 33-59, Atomic Bomb Casualty Commission, Hiroshima, 1959.
11. Y. Shimizu, K. Mabuchi, D. L. Preston and I. Shigematsu, Mortality study of atomic-bomb survivors: Implications for assessment of radiation accidents. World Health Stat. Q. 49, 35-9 (1996).
12. International Classification of Diseases: Manual of Statistical Classification of Diseases, Injuries and Causes of Death, 1975 Revision. Vol. 1. World Health Organization, Geneva, 1977.
13. D. A. Pierce, D. O. Stram and M. Vaeth, Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat. Res. 123, 275-284 (1990).
14. D. Clayton and M. Hills, Statistical Methods in Epidemiology. Oxford University Press, New York, 1993.
15. N. Breslow and N. Day, Statistical Methods in Cancer Research, Vol. II. The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 83, International Agency for Research on Cancer, Lyon, 1988.
16. D. Preston, J. Lubin, D. Pierce and M. McConney, Epicure Users Guide. Hirosoft International Corporation, Seattle, 1993.
17. D. A. Pierce and D. L. Preston, Joint analysis of site-specific cancer risks for the atomic bomb survivors. Radiat. Res. 134, 134-142 (1993).
18. UNSCEAR, Sources and Effects of Ionizing Radiation: United Nations Scientific Committee on the Effects of Atomic Radiation 2000 Report to the General Assembly, with Scientific Annexes, Vol. II: Effects. United Nations, New York, 2000.
19. UNSCEAR, Sources and Effects of Ionizing Radiation. United Nations Scientific Committee on the Effects of Atomic Radiation 1994 Report to the General Assembly with Scientific Annexes. United Nations, New York, 1994.
20. D. Thomas, S. Darby, F. Fagnani, P. Hubert, M. Vaeth and K. Weiss, Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys. 63, 259-272 (1992).
21. S. E. Feinberg, Method of statistical differentials. In Encyclopedia of Biostatistics (S. Kotz and N. L. Johnson, Eds.), Wiley-Interscience, New York, 1998.
22. National Research Council, Committee on the Biological Effects of Radiation, The Effects on Populations Exposed to Low Levels of Ionizing Radiation (BEIR V). National Academy Press, Washington, DC, 1990.
23. D. A. Pierce, G. B. Sharp and K. Mabuchi, Joint effects of lung cancer and smoking on lung cancer risk among atomic bomb survivors. Radiat. Res. 159, 511-520 (2003).
24. D. A. Pierce, Age-time patterns of radiogenic cancer risk: Their nature and likely explanations. J. Radiol. Prot. 22, A147-A154 (2002).
25. D. A. Pierce and M. Vaeth, Age-time distribution of cancer risks to be expected from acute or chronic exposures to general mutagens. Radiat. Res. 154, 727-728 (2000). [Extended Abstract; also see Discussion: Temporal Effects in Radiation and Epidemiology. Radiat. Res. 154, 730-731 (2000)]
26. D. A. Pierce and M. Vaeth, Age-time distribution of cancer risks to be expected from acute or chronic exposures to general mutagens. Radiat. Res. 154, 727-728 (2000). [Extended Abstract; also see Discussion: Temporal Effects in Radiation and Epidemiology. Radiat. Res. 154, 730-731 (2000)]
27. D. A. Pierce and M. Vaeth, Age-time patterns of cancer to be anticipated from exposure to general mutagens. Biostatistics 4, 231-248 (2003).
28. J. B. Cologne, S. Tokuoka, G. W. Beebe, T. Fukuhara and K. Mabuchi, Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat. Res. 152, 364-373 (1999).
29. D. L. Preston, A. Mattsson, E. Holmberg, R. Shore, N. G. Hildreth and J. D. Boice, Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat. Res. 158, 220-235 (2002).
30. M. Tokunaga, C. E. Land, S. Tokuoka, I. Nishimori, M. Soda and S. Akiba, Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat. Res. 138, 209-223 (1994).
31. International Union against Cancer and International Association of Cancer Registries. In Trends in Cancer Incidence and Mortality. (M. P. Coleman, Ed.). IARC Scientific Publications No. 121, International Agency for Research on Cancer, Lyon, 1993.
32. S. Fujiwara, G. B. Sharp, J. B. Cologne, S. Kusumi, M. Akahoshi, K. Kodama, G. Suzuki and H. Yoshizawa, Prevalence of hepatitis B virus infection among atomic-bomb survivors. Radiat. Res. 159, 780-786 (2003).
33. K. Neriishi, S. Akiba, T. Amano, T. Ogino and K. Kodama, Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Radiat. Res. 144, 215-221 (1995).
34. S. Fujiwara, S. Kusumi, J. Cologne, M. Akahoshi, K. Kodama and H. Yoshizawa, Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiat. Res. 154, 12-19 (2000).
35. H. Kato, M. Mhyumi, K. Nishioka and H. B. Hamilton, The relationship of hepatitis B surface antigen and antibody to atomic bomb radiation in the Adult Health Study sample, 1975-1977. Am. J. Epidemiol. 117, 610-620 (1983).
36. R. Sposto and D. L. Preston, Correcting for Catchment Area Nonresidency in Studies Based on Tumor Registry Data. CR 1-92, Radiation Effects Research Foundation, Hiroshima, 1992.
37. B. C. Choi, Definition, Sources, magnitude, effect modifiers, and strategies of reduction of the healthy worker effect. J. Occup. Med. 34, 979-988 (1992).
38. A. M. Stewart, Healthy worker and healthy survivor effects in relation to the cancer risks of radiation workers. Am. J. Ind. Med. 17, 151-154 (1990).
39. A. Stewart, A-bomb data: Detection of bias in the Life Span Study cohort. Environ. Health Perspect. 105 (Suppl. 6), 1519-1521 (1997).
40. A. Stewart and G. Kneale, A-bomb survivors: Factors that may lead to a re-assessment of the radiation hazard. Int. J. Epidemiol. 29, 708-714 (2000).
41. D. B. Richardson, S. Wing and W. Hoffmann, Cancer risk from low-level ionizing radiation: The role of age at exposure. Occup. Med. 16, 191-218 (2001).
42. W. F. Heidenreich, P. Jacob and H. G. Paretzke, Exact solutions of the clonal expansion model and their application to the incidence of solid tumors of atomic bomb survivors. Radiat. Environ. Biophys. 36, 45-58 (1997).
43. M. Kai, E. G. Luebeck and S. H. Moolgavkar, Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat. Res. 148, 348-358 (1997).
44. S. H. Moolgavkar, Multistage models and the A-bomb survivor data: implications for carcinogenic mechanisms? Radiat. Res. 154, 728-729 (2000). [Extended Abstract; also see Discussion: Temporal Effects in Radiation and Epidemiology. Radiat. Res. 154, 730-731 (2000)].
45. S. H. Moolgavkar, Multistage models and the A-bomb survivor data: implications for carcinogenic mechanisms? Radiat. Res. 154, 728-729 (2000). [Extended Abstract; also see Discussion: Temporal Effects in Radiation and Epidemiology. Radiat. Res. 154, 730-731 (2000)].
46. G. R. Howe and J. McLaughlin, Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat. Res. 145, 694-707 (1996).
47. J. D. Boice, Jr., D. Preston, F. G. Davis and R. R. Monson, Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat. Res. 125, 214-222 (1991).
48. E. Cardis, E. S. Gilbert, L. Carpenter, G. Howe, I. Kato, B. K. Armstrong, V. Beral, G. Cowper, A. Douglas and A. Fix, Effects of low doses and low dose rates of external ionizing radiation: Cancer mortality among nuclear industry workers in three countries. Radiat. Res. 142, 117-132 (1995).
49. National Research Council, Committee on the Biological Effects of Radiation, The Health Effects on Exposure to Indoor Radon (BEIR VI). National Academy Press, Washington, DC, 1998.
50. E. Ron, J. H. Lubin, R. E. Shore, K. Mabuchi, B. Modan, L. M. Pottern, A. B. Schneider, M. A. Tucker and J. D. Boice, Jr., Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat. Res. 141, 259-277 (1995).
51. F. G. Davis, J. D. Boice, Jr., Z. Hrubec and R. R. Monson, Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 49, 6130-6136 (1989).
52. Z. A. Carr, R. A. Kleinerman, M. Stovall, R. M. Weinstock, M. L. Griem and C. E. Land, Malignant neoplasms after radiation therapy for peptic ulcer. Radiat. Res. 157, 668-677 (2002).
53. C. E. Land, J. D. Boice, Jr., R. E. Shore, J. E. Norman and M. Tokunaga, Breast cancer risk from low-dose exposures to ionizing radiation: Results of parallel analysis of three exposed populations of women. J. Natl. Cancer Inst. 65, 353-376 (1980).
54. M. P. Little and J. D. Boice, Jr., Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat. Res. 151, 218-224 (1999).
55. R. W. Byhardt and W. T. Moss, The heart and blood vessels. In Moss' Radiation Oncology: Rationale, Technique (James D. Cox, Ed.), pp. 307-318. Mosby, St. Louis, 1994.
56. J. R. Stewart, Normal tissue tolerance to irradiation of the cardiovascular system. Front. Radiat. Ther. Oncol. 23, 302-309 (1989).
57. J. R. Stewart and L. F. Farfado, Radiation-induced heart disease. Clinical and experimental aspects. Radiol. Clin. North Am. 9, 511-531 (1971).
58. J. F. Boivin, G. B. Hutchison, J. H. Lubin and P. Mauch, Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69, 1241-1247 (1992).
59. S. L. Hancock, M. A. Tucker and R. T. Hoppe, Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J. Am. Med. Assoc. 270, 1949-1955 (1993).
60. L. F. Paszat, W. J. Mackillop, P. A. Groome, C. Boyd, K. Schulze and E. Holowaty, Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries, J. Clin. Oncol. 16, 2625-2631 (1998).
61. L. F. Paszat, W. J. Mackillop, P. A. Groome, K. Schulze and E. Holowaty, Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int. J. Radiat. Oncol. Biol. Phys. 43, 755-762 (1999).
62. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355, 1757-1770 (2000).
63. J. Cuzick, H. Stewart, L. Rutqvist, J. Houghton, R. Edwards, C. Redmond, R. Peto, M. Baum, B. Fisher and H. Host, Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 12, 447-453 (1994).
64. J. L. Haybittle, D. Brinkley, J. Houghton, R. P. A'Hern and M. Baum, Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. Br. Med. J. 298, 1611-1614 (1989).
65. L. E. Rutqvist and H. Johansson, Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br. J. Cancer 61, 866-868 (1990).
66. S. J. Dupre, Ed. Report to the Workers' Compensation Board on the Healthy Worker Effect. IDSP Report No. 3, Industrial Disease Standards Panel, Toronto, 1988.
67. S. C. Darby, R. Doll, S. K. Gill and P. G. Smith, Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer 55, 179-190 (1987).
68. M. L. Griem, R. A. Kleinerman, J. D. Boice, Jr., M. Stovall, D. Shefner and J. H. Lubin, Cancer following radiotherapy for peptic ulcer. J. Natl. Cancer Inst, 86, 842-849 (1994).
69. M. R. Alderson and S. M. Jackson, Long term follow-up of patients with menorrhagia treated by irradiation. Br. J. Radiol. 44, 295-298 (1971).
70. P. G. Smith and R. Doll, Late effects of x irradiation in patients treated for metropathia haemorrhagica. Br. J. Radiol. 49, 224-232 (1976).
71. F. G. Davis, J. D. Boice, Jr., J. L. Kelsey and R. R. Monson, Cancer mortality after multiple fluoroscopic examinations of the chest, J. Natl. Cancer Inst. 78, 645-652 (1987).
72. G. M. Matanoski, R. Seltser, P. E. Sartwell, E. L. Diamond and E. A. Elliott, The current mortality rates of radiologists and other physician specialists: specific causes of death, Am. J. Epidemiol. 101, 199-210 (1975).
73. M. Hauptmann, A. K. Mohan, M. M. Doody, M. S. Linet and K. Mabuchi, Mortality from diseases of the circulatory system in radiologic technologists in the United States. Am. J. Epidemiol. 157, 239-248 (2003).
74. A. Berrington, S. C. Darby, H. A. Weiss and R. Doll, 100 years of observation on British radiologists: Mortality from cancer and other causes 1897-1997. Br. J. Radiol. 74, 507-519 (2001).
75. C. R. Muirhead, A. A. Goodill, R. G. Haylock, J. Vokes, M. P. Little, D. A. Jackson, J. A. O'Hagan, J. M. Thomas, G. M. Kendall and G. L. Berridge, Occupational radiation exposure and mortality: Second analysis of the National Registry for Radiation Workers. J. Radiol. Prot. 19, 3-26 (1999).
76. V. K. Ivanov, A. I. Gorski, M. A. Maksioutov, A. F. Tsyb and G. N. Souchkevitch, Mortality among the Chernobyl emergency workers: Estimation of radiation risks (preliminary analysis). Health Phys. 81, 514-521 (2001).
77. T. Iwasaki, M. Murata, S. Ohshima, T. Miyake, S. Kudo, Y. Inoue, M. Narita, T. Yoshimura, S. Akiba and H. Matsudaira, Second analysis of mortality of nuclear workers in Japan, 1986-1997. Radiat. Res. 159, 228-238 (2003).
78. F. L. Wong, M. Yamada, H. Sasaki, K. Kodama, S. Akiba, K. Shimaoka and Y. Hosoda, Noncancer disease incidence in the atomicbomb survivors: 1958-1986. Radiat. Res. 135, 418-430 (1993).
79. S. Nagataki, Y. Shibata, S. Inoue, N. Yokoyama, M. Izumi and K. Shimaoka, Thyroid diseases among atomic bomb survivors in Nagasaki. J. Am. Med. Assoc. 272, 364-370 (1994).
80. S. Fujiwara, G. B. Sharp, J. B. Cologne, S. Kusumi, M. Akahoshi, K. Kodama, G. Suzuki and H. Yoshizawa, Prevalence of Hepatitis B Virus Infection among Atomic Bomb Survivors. MS 10-02, Radiation Effects Research Foundation, Hiroshima, 2002.
81. S. Kawamura, K. Kodama, Y. Shimizu, Y. Amasaki and K. Shimaoka, Prevalence of aortic arch calcification in the AHS population. Nagasaki Med. J. 67, 474-478 (1992).
82. F. Kasagi, K. Kodama, M. Yamada, H. Sasaki and M. Akahoshi, An association between the prevalence of isolated hypertension and radiation dose in the Adult Health Study. Nagasaki Med. J. 67, 479-482 (1992).
83. F. L. Wong, M. Yamada, H. Sasaki, K. Kodama and Y. Hosoda, Effects of radiation on the longitudinal trends of total Serum cholesterol levels in the atomic bomb survivors. Radiat. Res. 151, 736-746 (1999).
84. H. Sasaki, E. Wong, M. Yamada and K. Kodama, The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J. Clin. Epidemiol. 55, 974-981 (2002).
85. Y. Kusunoki, T. Hayashi, Y. Morishita, M. Yamaoka, M. Maki, M. A. Bean, S. Kyoizumi, M. Hakoda and K. Kodama, T-cell responses to mitogens in atomic bomb survivors: A decreased Capacity to produce interleukin 2 characterizes the T cells of heavily irradiated individuals. Radiat. Res. 155, 81-88 (2001).
86. K. Neriishi, E. Nakashima and R. R. Delongchamp, Persistent subclinical inflammation among A-bomb survivors. Int. J. Radiat. Biol. 77, 475-482 (2001).
87. T. Hayashi, Y. Kusunoki, M. Hakoda, Y. Morishita, Y. Kubo, M. Maki, F. Kasagi, K. Kodama, D. G. MacPhee and S. Kyoizumi, Radiation dose-dependent increases in inflammatory response markers in atomic bomb survivors. Int. J. Radiat. Biol. 79, 129-136 (2003).